ivst_admin – NovAccess Global

Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

NovAccess Global to Present at World Orphan Drug Congress

NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division

NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

NovAccess Global Announces Virtual Annual Shareholders’ Meeting

XSNX Shareholder Meeting

NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1

Orphan Drug Application Filing

NovAccess Global Announces Fireside Chat with Board Member Perspectives

NovAccess Global Announces Fireside Chat Series for the Investment Community

XSNX Fireside Chat

NovAccess Global Announces Effectiveness of Form S1 Registration Statement

Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Forward-Looking Statements

Contact Us

JOIN US

Stay up-to-date with our journey

Privacy Policy

Forward-Looking Statements